A detailed history of Mmbg Investment Advisors Co. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mmbg Investment Advisors Co. holds 13,879 shares of AZN stock, worth $965,562. This represents 0.12% of its overall portfolio holdings.

Number of Shares
13,879
Previous 7,459 86.07%
Holding current value
$965,562
Previous $488,000 109.02%
% of portfolio
0.12%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

BUY
$65.37 - $77.96 $419,675 - $500,503
6,420 Added 86.07%
13,879 $1.02 Million
Q4 2024

Feb 14, 2025

BUY
$63.2 - $79.58 $104,280 - $131,307
1,650 Added 28.4%
7,459 $488,000
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $445,376 - $508,984
5,809 New
5,809 $452,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $216B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Mmbg Investment Advisors Co. Portfolio

Follow Mmbg Investment Advisors Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mmbg Investment Advisors Co., based on Form 13F filings with the SEC.

News

Stay updated on Mmbg Investment Advisors Co. with notifications on news.